转移性前列腺癌接受重症治疗患者住院姑息治疗的时间趋势与社会障碍
基于美国全国住院患者样本数据库2004-2015年数据,4168例接受重症治疗的转移性前列腺癌患者中11.3%使用了住院姑息治疗。姑息治疗使用率从1.2%升至22.3%(EAPC +19.6%,p<0.001),教学医院和非裔美国人种族分别与较高和较低使用率独立相关。
要点
- 转移性前列腺癌重症患者住院姑息治疗使用率从2004年1.2%升至2015年22.3%
- 教学医院与较高姑息治疗使用率独立相关(OR 1.74,p<0.001)
- 非裔美国人种族与较低姑息治疗使用率独立相关(OR 0.66,p<0.001)
核心结论
- 2004至2015年间接受重症治疗的转移性前列腺癌患者住院姑息治疗使用率大幅上升。
- 非裔美国人种族和非教学医院状态是较低姑息治疗使用率的独立预测因素。
- 南部、白种人和教学医院的姑息治疗使用率随时间增长最高。
研究设计与样本
- 回顾性分析美国全国住院患者样本数据库(2004-2015年)。
- 纳入4168例接受重症治疗的转移性前列腺癌患者。
- 使用单变量估计年度百分比变化分析和多变量逻辑回归模型(医院水平聚类调整)。
主要发现
- 449例(11.3%)接受了住院姑息治疗。
- 住院姑息治疗使用率从1.2%增至22.3%(EAPC +19.6%,p<0.001)。
- 南部使用率从0增至25.4%(EAPC +27.6%),白种人从1.5%增至24.4%(EAPC +19.8%,p<0.001),教学医院从0.9%增至26.2%(EAPC +19.6%,p<0.001)。
- 多变量模型中,教学医院状态(OR 1.74,p<0.001)和较近年份区间(OR 4.63,p<0.001)与较高住院姑息治疗率相关。
- 非裔美国人种族(OR 0.66,p<0.001)、入院主要诊断为泌尿生殖系统疾病(OR 0.49,p<0.001)和胃肠道疾病(OR 0.61,p=0.02)与较低住院姑息治疗率相关。
临床怎么用
- 应关注非裔美国人转移性前列腺癌重症患者,其住院姑息治疗使用率较低。
- 非教学医院是改善住院姑息治疗提供的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Use of inpatient palliative care (IPC) in advanced cancer patients represents a well-established guideline recommendation. A recent analysis demonstrated that genitourinary (GU) cancer patients benefited of IPC at the second lowest rate within the four examined primaries, namely lung, breast, colorectal, and GU. Based on this observation, we examined temporal trends and predictors of IPC use in metastatic prostate cancer patients receiving critical care therapies (CCT). MATERIALS AND METHODS: We identified mPCa patients receiving CCT within the Nationwide Inpatient Sample database (2004-2015). IPC use rates were evaluated using univariable estimated annual percentage changes analyses. Multivariable logistic regression (MLR) models were used after adjustment for clustering at hospital level. RESULTS: Of 4168 mPCa patients receiving CCT, 449 (11.3%) received IPC. IPC use increased from 1.2 to 22.3% (EAPC: +19.6%, p < 0.001). After stratification according to regions, race, and teaching status, the highest increase of IPC use was recorded in the South (from 0 to 25.4 %, EAPC: +27.6%), in Caucasians (from 1.5 to 24.4 %, EAPC: +19.8%; p < 0.001) and in teaching hospitals (from 0.9 to 26.2 %, EAPC: +19.6%; p < 0.001). In MLR models, teaching status (Odds ratio [OR]: 1.74, p < 0.001) and contemporary year interval (OR: 4.63, p < 0.001) were associated with higher IPC rates. Conversely, African American race (OR: 0.66, p < 0.001) and primary diagnosis of GU disorders (OR: 0.49, p < 0.001) and gastrointestinal (GI) disorders at admission (OR: 0.61, p = 0.02) were associated with lower IPC rates. CONCLUSIONS: IPC use rate in mPCa patients receiving CCT sharply increased between 2004 and 2015. The highest increase of IPC use across time was recorded in the South, in Caucasian race, and in teaching hospitals. African-American race and nonteaching status were identified as independent predictors of lower IPC use and represent targets for efforts aimed at improving IPC delivery in mPCa patients receiving CCT.
引用
- Mazzone E, Mistretta FA, Knipper S, et al. Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies. Prostate Cancer Prostatic Dis. 2019. PMID: 31685982. doi:10.1038/s41391-019-0183-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。